Impact of<i>Lycium barbarum</i>arabinogalactan on the fecal metabolome in a DSS-induced chronic colitis mouse model-Reference-Cited by-同舟云学术

Impact ofLycium barbarumarabinogalactan on the fecal metabolome in a DSS-induced chronic colitis mouse model

Published:2022 Issue:16 Volume:13 Page:8703-8716
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Cao Cui¹²³,Wang Linlin¹²,Ai Chunqing¹²^ORCID,Gong Guiping³,Wang Zhongfu³^ORCID,Huang Linjuan³^ORCID,Song Shuang¹²^ORCID,Zhu Beiwei¹²^ORCID

Affiliation:

1. Collaborative Innovation Center of Seafood Deep Processing, National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, P. R. China

2. National and Local Joint Engineering Laboratory for Marine Bioactive Polysaccharide Development and Application, Dalian Polytechnic University, Dalian 116034, P. R. China

3. Shaanxi Natural Carbohydrate Resource Engineering Research Center, College of Food Science and Technology, Northwest University, Xi'an 710069, P. R. China

Abstract

Gut microbes and untargeted/targeted metabolomics were combined to comprehensively understand the therapeutic effect and the underlying mechanism ofLycium barbarumarabinogalactan (LBP-3) in DSS-induced colitis mice.

Funder

Shaanxi Key Science and Technology Innovation Team Project

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/FO/D2FO01283A

Reference71 articles.

1. Ulcerative colitis

2. Inflammatory Bowel Disease